Cannabis, marijuana and Hemp stock news from Investorideas.com plus daily cannabis #potcasts - Investor Ideas #Potcasts #Cannabis News and Stocks on the Move
Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (OTCQB: $GBLX) (TSX: $APHA.TO) (NYSE: $APHA) and BuyWell.com
This month's cannabis podcasts brought to you by CLS Holdings USA, Inc. (OTCQB: $CLSH) @CLSHusa
Delta, Kelowna, BC - December 12, 2018 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca and its exclusive content partner, CLS Holdings USA, Inc. (OTCQB: CLSH), release today's edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
CLS Holdings USA, Inc. (OTCQB: CLSH) is a diversified cannabis company operating as Cannabis Life Sciences an integrated cannabis producer and retailer in Nevada through its Oasis Cannabis subsidiaries with plans to expand into other States.
Good afternoon, welcome to another Investorideas.com "potcast", featuring stocks to watch, cannabis news as well as insights from thought leaders and experts.
But first, the big news from yesterday was the US Senate passing the 2018 Farm Bill. The 2018 Farm Bill, known as the "Agriculture Improvement Act of 2018," defines hemp as follows: "The term 'hemp' means the plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis. The key takeaways from the bill regarding hemp and CBD were the removal of hemp from the Controlled Substances Act; conferring on the Department of Agriculture (DOA) authority over hemp, including CBD derived from hemp; States desiring to have primary regulatory authority over hemp must submit a plan to DOA pursuant to which the state will establish hemp regulations to provide for the growth and use of hemp, including CBD derived from hemp; no laws will be erected to prohibit the interstate transportation of hemp or CBD derived from hemp; The Food and Drug Administration may intensify its involvement with CBD as more products for human consumption hit the market; Banking and insurance for hemp-derived CBD products should become increasingly available as those products are no longer "unlawful"; and finally CBD derived from unlawful marijuana is still unlawful.
There is also currently pending in Congress bipartisan legislation that would confer on states the authority to regulate marijuana. The 2018 Farm Bill, which confers on states the authority to regulate hemp, could be a precursor and a good model for such states' rights marijuana legislation.
GB Sciences, Inc. announced that their first crop in the rapidly expanding hemp market expects to yield a gross profit of $0.7million dollars as well as seeds and genetics. These seeds and genetic information will provide the mother plants in order to expand the program, which should prove to be a significant revenue generator for the Company.
An integral part of the Company's success is its partnership with The Colorado Hemp Project (CHP). "Wild Bill" Billings co-founded the company with his daughter in order to educate farmers on the value of growing hemp and to then find the right partner for their crop.
"GB Sciences told us what they wanted out of the plants, and we worked together to fill in the blanks," remarked Wild Bill. "GB Sciences understands the magic of this plant and it's future. Real soon, everyone will have hemp supplements and food in their daily diets. And that's a good thing."
"For GB Sciences, The Colorado Hemp Project provided unique genetics to explore, sourced the land, found the right farmers and the production resources necessary to take the project from seed to sale." Remarked GB Sciences' Chief Science Officer, Andrea Small-Howard.
Aphria Inc. today announced that it has signed a Letter of Intent with Insumos Medicos S.A., a Paraguayan pharmaceutical manufacturing, import and distribution company, to enter into an exclusive supply and distribution agreement to provide medical cannabis in Paraguay.
"Latin America continues to represent an important growth opportunity within the global medical cannabis industry, and we are excited to be among the first to enter the rapidly emerging market in Paraguay," said Jakob Ripshtein, President of Aphria. "Our strategic partner, Insumos, is well-positioned to establish a leading presence for the Company's products throughout the country. Aphria will continue to expand its footprint in the most strategic markets in Latin America and around the world through its diversified approach to innovation, partnerships and expansion."
Insumos is a distributor of pharmaceuticals to hospitals within Paraguay. Insumos has the network, relationships, and reach to bring Aphria's products to patients in need across the country. As part of the proposed agreement, Insumos will undertake the registration of Aphria's products with Paraguay's Ministry of Public Health and Social Welfare and appropriate licensing for the import of medical cannabis.
GTEC Holdings Ltd. announced that its common shares have been approved for up-listing of trading onto the OTCQB Venture Market, a US trading platform that is operated by the OTC Markets Group in New York. Effective immediately, the Company will commence trading on the OTCQB under the symbol "GGTTF". The Company's common shares will continue to trade on the TSX Venture Exchange under the symbol "GTEC". In addition, the Company announced that it has received DTC eligibility by The Depository Trust Company ("DTC") for electronic settlement and transfer of its common shares in the United States.
The OTCQB is the premier marketplace for entrepreneurial and development stage US and international companies that are committed to providing a high-quality trading and information experience for their US investors. To be eligible, companies must be current in their financial reporting, pass a minimum bid price test, and undergo an annual company verification and management certification process. The OTCQB quality standards provide a strong baseline of transparency, as well as the technology and regulation to improve the information and trading experience for investors. The ability to have the Company's shares electronically transferred between brokerages in the US is significantly more convenient and reduces the costs incurred in trading shares. When shares are able to trade electronically, existing investors benefit from greater liquidity and execution speeds, while opening the door to new investors that may have been previously restricted from the Company's shares.
BuyWell.com, Canada's first fully integrated Health and Wellness marketplace, introduced BuyWell Care: Canada's first guaranteed issue Medical Cannabis Coverage Plan and Medical Cannabis Savings Calculator.
Through BuyWell Care, patients can use the Calculator to see how much they can save on their medical cannabis while purchasing coverage plans through the online application process.
The program will be directed under the guidance of Dr. Ira Price, MD, FRCPC, Medical Director of Synergy Health Services. BuyWell Care's coverage will include treatments using cannabis oils, dried flower and gel capsules commencing December 12th, 2018.
Dr. Price commented, "BuyWell Care's inclusion of coverage for medical cannabis is a true example of the paradigm shift that's sweeping through the medical landscape. It's a breath of fresh air."
Based on research and findings from Synergy Health Services, BuyWell Care consumers may realize savings of up to $5,700 per year on their medical cannabis.
"For hard-working Canadians who rely on medical cannabis as part of their treatment regimen, BuyWell Care's Medical Cannabis Coverage Plan provides a revolutionary way to save money on their expensive medication," said Amanda LeBlanc, co-founder of BuyWell.com.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
CLS Holdings USA, Inc. (CLSH) is a diversified cannabis company that, subject to receipt of certain anticipated regulatory approvals, acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada, and plans to expand to other states.
CLS stands for "Cannabis Life Sciences," in recognition of the Company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The Company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
Get the cannabis/hemp stock directory as an Investor ideas member, plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move. Learn more https://www.investorideas.com/membership/
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.
Disclosure this podcast is in partnership with featured sponsor CLS Holdings USA, Inc. (OTCQB: CLSH) details :
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Metrospaces (OTC: $MSPC) Seize Upon Real Estate Market Opportunities in the #Cannabis Space; Companies discussed: (NYSE: $ACB) (TSX: $ACB.TO) (NASDAQ: $CRON) (TSX: $CRON.TO) (NYSE: $MO) (CSE: $CROP.C) (OTC: $CRXPF)
Point Roberts, WA and Delta, BC - December 12, 2018 (Investorideas.com Newswire) Investorideas.com, a leading investor news resource covering real estate and cannabis stocks releases a snapshot looking at the synergistic opportunity for both sectors.
As the emerging cannabis market explodes with increased legalization across North American markets, Metrospaces, Inc. (OTC:MSPC) Company Executive President, Mr. Oscar Brito, highlights the considerable market opportunities in real estate that many investors may have overlooked.
Listen to the podcast interview with Oscar Brito, Metrospaces, Inc.:
Metrospaces, Inc. (OTC: $MSPC) President, Oscar Brito, Talks about Real Estate Opportunities in #Cannabis Market
Metrospaces, Inc., a real estate investment firm that invests in operating companies, has made moves in the cannabis space. Brito said the emerging market is growing too fast to ignore and that most of the attention of institutional investors has been focused on aspects other than real estate.
"We're looking around for new opportunities in the marketplace and obviously cannabis is something that is getting to the point where you just can't ignore it any longer," he said. "Everybody jumps into the operating side and that's where the money has really been rushing into. At the same time, we've seen [that] the real estate side has been completely ignored or largely ignored by institutional investors."
The interest of a company like Metrospaces reflects wider trends in the cannabis market that have seen significant market opportunity where legalization has taken effect. An article on Crew Network analyzes the real estate boom that cannabis has helped to instigate in certain parts of the U.S. Pointing out that the sector relies on real estate for cultivation, manufacturing, warehousing and brick-and-mortar stores, the article argues that in cities where it is already legal, cannabis is causing "a spike in warehouse and other industrial property values". The article adds that:
"Data centers, self-storage properties and factories are all being repurposed for cultivation and manufacturing of marijuana. Land values have escalated in states where outside cultivation is permitted."
This is further reflected by the experience in Canada, where a so-called "green rush" is resulting from recreational cannabis legalization on the federal level in October. A piece in the Financial Post cites research from real estate consulting firm Altus Group, indicating that "marijuana-growing facilities have already consumed 8.7 million square feet in the first nine months of 2018," and that "another six-plus-million square feet are in the pipeline". An example of this is Aurora Cannabis Inc.'s (NYSE:ACB) (TSX: ACB) construction of an 800,000 square-foot facility near Edmonton, Alberta, helping to propel that city's commercial real estate sales value to over $1 billion.
More recently it was announced that tobacco company Altria (NYSE:MO) had acquired 45 percent of Cronos Group, Inc. (NasdaqGM:CRON) (TSX: CRON) stock and would convert existing tobacco farmland into cannabis farmland.
However, as with Metrospaces, it isn't only operators that are taking advantage of the market opportunity. Crop Infrastructure Corp. (CSE:CROP) (OTC: CRXPF), a company that constructs, owns and leases real estate solutions to cannabis operators, has massively expanded their portfolio recently. The company announced on December 6 that it had begun a first phase development covering 1,729,000 square feet (40 acres) of outdoor cannabis and 60,000 square feet of greenhouse at its 1,000-acre cannabis farm in Nevada.
Brito said the position was ideal, as it allows companies like Metrospaces to stick with property without having to worry about the frequently troublesome regulation of the cannabis sector itself.
"We like this quite a bit because we can do what we do best – which is invest in real estate – and being on the real estate side lets you cover yourself from the regulatory situation that we have now, where in some places it's illegal and it's still federally prohibited," he said.
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
This news is published on the Investorideas.com Newswire – News that Inspires big ideas Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: this news article and podcast featuring Metrospaces is a paid for news release on Investorideas.com – third party , Learn more about costs and our services https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Point Roberts, WA and Delta, BC - December 12, 2018 (Investorideas.com Newswire) Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at the growing opportunity for the CBD pet market and how companies that are positioned in the cannabis space are adding pet markets to their growing portfolios.
According to the American Pet Products Association (APPA), $69.51 billion was spent on pets in the U.S in 2017 and it's estimated that number will grow to $72.13 billion for 2018. Canadians spend $6.6 billion a year on their pets according to recent numbers.
Looking at how cannabis/CBD plays into the pet market, CTV reported, "In 2017, sales of cannabis products marketed for pets at medical and adult-use cannabis dispensaries was nearly $7 million in California, Colorado, Oregon and Washington, according to BDS Analytics. In Colorado, sales of pet products grew 49 per cent in 2017, versus growth across all product categories at 15 per cent, it said."
Canopy Animal Health, stated as the global leader in cannabinoid science for pets, is a a division of Canopy Health, a wholly owned subsidiary of Canopy Growth Corporation (TSX:WEED), (NYSE:CGC). In August they announced that approval had been received from the Veterinary Drug Directorate of Health Canada to research the effectiveness of cannabidiol ("CBD") to treat anxiety in certain animals.
Continued: The research will be conducted by Canopy Animal Health, a division of Canopy Health which focuses on developing cannabis-based healthcare products for companion animals. The approval comes in the form of a No Objection Letter for the use of a proprietary CBD enriched oil formulation, previously administered in preclinical dosing and safety studies, as a potential therapy for anxiety. The CBD formulation will be produced by Canopy Growth in its GMP-certified production facility in Smiths Falls, Ontario.
From the release: "Our passion to create safe and effective products for animals is driven by the love we share for our pets," commented Marc Wayne, Managing Director, Canopy Health
Innovations. "The use of natural-occurring cannabinoids as a therapy for companion animals is a logical new forefront of medical discovery and the research we are working on at CAH is world leading. These trial approvals mark a significant milestone on the journey of making cannabis-based drugs accepted and recommended by veterinarians."
Trying to set their own paw print in the sector, EnviroTechnologies International, Inc. (OTC: ETII) , just reported that its subsidiary, CBD Health Co., (www.cbdhealthco.com), a company that markets and sells high quality and proprietary hemp-based, natural CBD health products, is progressing in its hemp-based pet supplement products development.
From the news: "Much has been written lately about CBD products and the numerous applications for humans and pets, which has raised consciousness of CBD's therapeutic value. Our CBD products are all cannabidiol-based, which means they are not psychoactive and are safe for pets," said Joe De Leon, CBD's President. "When your pet gets sick, you want the best treatment available and the products we are developing will offer better, more effective and safer medicinal options for pets than traditional pet health products."
Continued: Current research shows that there are several common CBD benefits for dogs, which are, 1) powerful painkiller (the ECS is involved in managing pain and CBD's pain killing properties are well documented); 2) effective anticonvulsant (CBD helps control seizures, tremors, tics and spasms); 3) natural anti-inflammatory; 4) anxiety and stress reducer (anxiety in dogs often results in barking, urination and defecation, chewing and aggression); 5) active antiemetic (reduces nausea and vomiting); and homeostasis promoter (proper functioning of the body).
"Pet owners are committed to their pet's health and well-being and are willing to spend money on pet health products, which make this a multi-billion dollar market, worldwide," said Karren. "We hope to introduce our CBD pet products in 2019 as we believe that our CBD pet products will be superior to those currently offered in this huge industry and will create another profitable channel for our CBD products."
Earlier this year, CannTrust Holdings Inc. (TSX: TRST), one of Canada's leading licensed producers of medical cannabis, announced it entered into a letter of intent with privately-owned company, Grey Wolf Animal Health Inc., to develop groundbreaking cannabis products to support the well-being of pets.
From the news: There are approximately 16 million cats and dogs in Canada with almost two-thirds of Canadian households owning a pet. Canadian pet owners are increasingly treating pets as an extension of their family. With over 350 million pets globally, there is a sizeable market opportunity for cannabis products.
Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) announced in October it will be launching Pawceuticals, a CBD-based product line that naturally aids in restoring a pet's health and improving overall wellness.
While these companies are not solely focused on the pet market, it is another revenue door to open in the CBD market. Investors and industry leaders see further substantial growth for the sector as the US Farm Bill gets closer to reality, as of on Dec. 11th, the Senate voted 87 to 13 to pass the 2018 Farm Bill
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
This news is published on the Investorideas.com Newswire - News that Inspires big ideas Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: this news article featuring ETII is a paid for news release on Investorideas.com - third party , Learn more about costs and our services https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
